• OUE Lippo Healthcare to acquire a 10.63% stake in SGX-ST listed First REIT;
  OUE Lippo Healthcare and OUE Limited to acquire 40% and 60% respectively of the shares in Bowsprit Capital Corporation Limited, the manager of First REIT;
• Proposed Acquisitions are consistent with OUE Lippo Healthcare’s Pan-Asian and asset-light growth strategy; being earnings accretive and cash flow generating, Proposed Acquisitions are also expected to enhance shareholder value; and
• Proposed Acquisitions by OUE Lippo Healthcare are expected to be funded by proceeds from a 1-for-1 renounceable underwritten rights issue by OUE Lippo Healthcare of approximately S$150m, which is supported by major shareholders OUE Limited and ITOCHU Corporation.

SINGAPORE, Sept. 18, 2018 /PRNewswire/ — OUE Lippo Healthcare Limited (“OUELH” or the “Company” and together with its subsidiaries, the “Group”), the healthcare subsidiary of OUE Limited (“OUE”), today announced the proposed acquisition of approximately 10.63% of First REIT’s total issued units (“Proposed Units Acquisition”). The Company has also proposed the acquisition of a 40% stake in Bowsprit Capital Corporation Limited (“Bowsprit”), the manager of First REIT (together with the Proposed Units Acquisition, the “Proposed Acquisitions”). The Proposed Acquisitions’ total consideration will amount to approximately S$142 million. OUELH’s parent, OUE, will concurrently acquire the other 60% stake in Bowsprit.

Listed on the Main Board of the Singapore Exchange Trading Limited (the “SGX-ST”) since 2006, First REIT is the SGX-ST’s first listed healthcare real estate investment trust. It currently has a portfolio of 20 high quality healthcare-related properties with stable cash flows and long lease terms across Indonesia, Singapore, and South Korea.

With First REIT’s significant presence in key Asian markets such as Indonesia, and owning diverse yield-accretive healthcare-related real estate assets throughout Asia, the Proposed Acquisitions of stakes in First REIT and its manager, Bowsprit, fit into OUELH’s geographical expansion plans. The Proposed Acquisitions will also position the Group to ride on a business eco-system of growth through investments, operations, asset management, and capital recycling for reinvestments.

Mr Lee Yi Shyan, Chairman of OUELH said, “The Proposed Acquisitions will bring three key benefits to OUELH’s long-term strategic goals. Firstly, they enable the Company to diversify into a key healthcare market such as Indonesia. Further, they fit well with our asset-light growth model and thirdly, they are earnings accretive, which enhances shareholders’ value.”

Based on the audited financial results of First REIT and Bowsprit for FY2017, the Proposed Acquisitions are expected to contribute earnings of 0.26 cents per share and distribution of S$7.1 million to the Group.

Major shareholders OUE and ITOCHU to support Rights Issue

To fund the Proposed Acquisitions, the Company is launching a renounceable underwritten rights issue to raise approximately S$150 million in gross proceeds (“Rights Issue”). The Rights Issue will also strengthen the Company’s balance sheet.

The Company is proposing to issue 2,221,564,603 new shares (each a “Rights Share”) at an issue price of S$0.0675 per Rights Share, on the basis of one Rights Share for every one existing ordinary share held by entitled shareholders as at the books closure date.  

Demonstrating their support for the Proposed Acquisitions and commitment towards OUELH’s future growth plans, OUE and ITOCHU Corporation have given irrevocable undertakings to fully subscribe for their entitlements under the Rights Issue. As at 18 September 2018, OUE owns a 64.35% stake in OUELH through Treasure International Holdings Pte. Ltd., while ITOCHU Corporation owns a 25.32% stake in OUELH through Browny Healthcare Pte. Ltd.. The placement to Browny Healthcare Pte. Ltd. of its shares in OUELH was completed in February 2018 at S$0.140 per share.

OUELH will be seeking the approval of its shareholders for the Proposed Acquisitions at an extraordinary general meeting to be convened, and the circular to shareholders will be despatched in due course. ITOCHU Corporation, through Browny Healthcare Pte. Ltd., has given an irrevocable undertaking to vote in favour of the Proposed Acquisitions at the extraordinary general meeting.

Oversea-Chinese Banking Corporation Limited is the sole financial advisor to the Company for the Proposed Acquisitions, and the manager and underwriter for the Rights Issue.

About OUE Lippo Healthcare Limited

OUELH is a subsidiary company of OUE Limited. OUELH provides high quality and sustainable healthcare solutions through the acquisition, development, management, and operations of healthcare facilities. The Company currently owns healthcare and related facilities in Japan and China, and continually seeks to expand its portfolio across pan-Asia.

For the latest news from OUELH, visit www.ouelh.com.

This Press Release is to be read in conjunction with the announcements dated 18 September 2018 by OUELH in relation to the Proposed Acquisitions and Rights Issue. All capitalised terms which are used in this Press Release but are not otherwise defined herein shall have the same meanings ascribed to them in the aforementioned announcements.

This Press Release has been prepared by the Company and its contents have been reviewed by PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor”), for compliance with the SGX-ST Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this Press Release.

This Press Release has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this Press Release, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this Press Release.

The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg

Logo – https://photos.prnasia.com/prnh/20180918/2240793-1LOGO

SINGAPORE, Sept. 17, 2018 /PRNewswire/ — In a partnership with the National Cancer Centre Singapore (NCCS), Amorepacific held a beauty workshop, makeup your Life, to educate female cancer patients on how to care for skin that is affected by cancer treatments. In its second year running, the event was held on 15 September 2018 and saw a total of 44 participants come together in 2 sessions of a 2-hour workshop.

Amorepacific Singapore empowers female cancer patients with ‘makeup your Life’ campaign.

Amorepacific Singapore empowers female cancer patients with ‘makeup your Life’ campaign.

Amorepacific Singapore empowers female cancer patients with ‘makeup your Life’ campaign.

Amorepacific Group launched the makeup your Life initiative in 2008, and subsequently rolled out the campaign across various Asian countries, with Singapore launching in 2017. This is Amorepacific’s first global corporate social responsibility (CSR) campaign and is currently executed across six countries and regions, including mainland China, Hong Kong, Taiwan, Vietnam and with Thailand scheduled to join in this year as well. Between 2008 and 2017, this campaign has benefited 14,040 female cancer patients and involved 5,241 volunteers from the company.

When undergoing cancer treatments like chemotherapy, many cancer patients often encounter a variety of skin reactions which can range from mild to severe in intensity. At this workshop, cancer patients are educated on the effects of chemotherapy on their skin, how to care for skin, as well as tips on makeup application. With empowerment of skills, the patients can understand how to take better care of their skin to enhance their confidence as they return to social or work life.

“Through makeup your Life, Amorepacific hopes to add a little colour to the lives of female cancer patients by helping them to restore confidence through sharing tips on how to care for their skin and enhance their features,” says Lysan Chew, General Manager of Amorepacific Singapore. “This is not just a one day event, but rather a collective effort by participating parties to do their part to help cancer patients lead a more beautiful life.“

This is the second year that Amorepacific Singapore has partnered NCCS on this campaign. “Our patients were very happy after the workshop. They really appreciated the expert makeup tips that catered specifically to the common skin problems encountered during cancer treatment. Many also said that meeting fellow cancer survivors and sharing their stories made them feel less alone and overwhelmed. Such emotional and practical support goes a long way to boosting confidence and helping in our patients’ journey back to health!” says Dr. Veronique Tan, Senior Consultant in the Division of Surgical Oncology, NCCS, and Head of SingHealth Duke-NUS Breast Centre.

The makeup your Life campaign is part of a ’20 by 20′ initiative by Amorepacific, which represents its commitment to beautifying the lives of 200,000 women by contributing to their health, wellbeing and economic development. Operated mainly in Korea and China, this initiative aims to contribute to reducing the mortality rate of female cancer and in improving the lives of female cancer patients. In these regions, the initiative extends to preventive education and screening measures to funding surgery for women who fall within the low-income group.

ABOUT AMOREPACIFIC GROUP

Since 1945, Amorepacific has had a single, clear mission: to present its unique perception of beauty — namely what it calls ‘Asian Beauty’ — to the world. As Korea’s leading beauty company, Amorepacific draws from its deep understanding of both nature and human to pursue harmony between inner and outer beauty. With its portfolio of over 20 cosmetics, personal care, and health care brands, Amorepacific is devoted to meeting the various lifestyles and needs of global consumers around the world: Asia, North America, and Europe. Amorepacific’s research hubs located around the world are dedicated to sustainable R&D that combine the best of natural Asian ingredients and advanced bio-technology. With its world-class products, Amorepacific is acclaimed for the innovative ways in which it is transforming global beauty trends. For more information on Amorepacific CSR initiatives, please visit www.apgroupcsr.com.

ABOUT THE NATIONAL CANCER CENTRE SINGAPORE

National Cancer Centre Singapore (NCCS) provides a holistic and multi-disciplinary approach to cancer treatment and patient care. We treat almost 70 per cent of the public sector oncology cases, and they are benefiting from the sub-specialisation of our clinical oncologists. To deliver among the best in cancer treatment and care, our clinicians work closely with our scientists who conduct robust cutting-edge clinical and translational research programmes which are internationally recognised.  NCCS strives to be a global leading cancer centre, and shares its expertise and knowledge by offering training to local and overseas medical professionals. For more information on NCCS, please visit www.nccs.com.sg.

Photo – https://photos.prnasia.com/prnh/20180917/2239341-1-a
Photo – https://photos.prnasia.com/prnh/20180917/2239341-1-b  
Photo – https://photos.prnasia.com/prnh/20180917/2239341-1-c  
Logo – https://photos.prnasia.com/prnh/20180416/2078707-1-logo  

CHENGDU, China, Sept. 17, 2018 /PRNewswire/ — Upon invitation, Magicare, an excellent enterprise of Chengdu Tianfu Software Park, will show the world the intellectualization and big data application of aged care at the Smart City Brains section of the 2018 World Artificial Intelligence Conference on September 17. Magicare is the only intelligent aged care enterprise invited to the conference. Its insights into and analysis of the “internet plus health care” field has represented the latest exploration and development of China’s aged care industry under the technological impact.

In the context of the increasingly severe trend of population aging, the concept of “intelligent old-age care” emerged at the right moment for the purpose of improving and guaranteeing the life qualities of aged people. As a start-up enterprise of “internet plus aged care”, Chengdu Magicare Technology Co., LTD. has been incubated successfully in Chengdu Tianfu Software Park and has taken the lead in the industry. As Magicare’s CEO He Wei said, its intelligent aged care and nursing system which was developed and researched independently has had group customers of 60 corporations. With the market share ranking number one in China, the system has been implemented in 30 cities. Magicare is the first enterprise of China to possess intelligent aged care and nursing products and also the first to export such technologies to Finland and Japan.

Status quo: a shortage of nursing resources

As the data showed, the number of aged people in China has reached as many as 211 million in 2014, including 200 million having home-based care, 8 million having community support and 3 million having institution care. Until 2020, the number of aged people will keep rising continuously, while the number of the aged who will need community support for elderly life will rise to 17.01 million, and the number of aged people needing institutional care will reach 7.29 million.

“Now, the shortage of nursing resources has been a tremendous difficulty in the aged care industry,” He Wei, Magicare’s CEO said. China’s Ministry of Civil Affairs has issued statistics that the shortage of aged care and nursing workers was about more than 12 million. Wei continued: “The proportion of nursing attendants in the nursing institutions for the aged is between 1 to 15 and 1 to 20. That is to say, one attendant needs to take care of 15-20 aged people, while the nursing attendant proportion in Japan is 1 to 3 and that in Hong Kong is 1 to 4.” To change this situation, many universities in China have gradually established the aged care and nursing major to cultivate human resources. “However, in the long cultivation period, we must think about how to define ‘China’s age-people caring mode’ and how to solve all kinds of difficulties in aged care,” said Wei.

Thought: a coverage of three aged care modes

Some scholars raised the concept of “9073” for the current situations of old-age care in China, which means 90% of the aged people spend their old age at home, 7% in the communities and 3% in the nursing institutions for the aged. However, through the profound investigations for the aged care industry in these several years, He Wei raised a different view: “The aged people would choose to live their old age at home when their bodies are in a relatively healthy state, and they would choose community care when they become older. They will choose professional institution to spend their old age when their health condition is really poor. These three modes are mutually complementary and indispensible.” He Wei plans to provide services and solve problems with scientific and technological methods, taking aged people care institutions as the starting step, community care for the aged people as the second step and home-based care for the aged people as the last step.

To collect data from the front-line old age caring institutions, the programmers of “Magicare” moved into the old age caring institutions, lived and ate together with the aged people. With eight months’ in-depth life there, the technologists designed a whole set of software and hardware products according to the most practical and demanding needs of the elderly people. To convert the design into products, He Wei had no experience to learn from. On the upstream, the parts-makers had no data. On the downstream, the foundry didn’t have an assembly method, a production technique, nor was it clear about the quality test standards. The first order of Magicare only included ten bracelets. “With continuous hardships and repetitive experiments for two years, we finally launched the first set of commercial products,” said Wei. In the entrepreneurial process, He Wei has met with more than one hundred investors. Continuous negations and doubts haven’t changed his determination of showing his respect to the old age caring cause: “We have also got many supports in this career. Tianfu Software Park has provided us offices free for three years, which has been a very great help for we frugal enterprise starters.”

Now, Magicare has already accomplished the exploration for intelligent care and nursing of institutional aged care. As for community and home-based aged care, He Wei put forward his view: home-based aged care must depend on community. The internet is not accessible to the majority of aged people, and thus it can only reach them through community offline service stores.” On learning from the experience of internet S2C thought, Magicare began to integrate resource S terminal to provide energies for the C terminal and expanded the exploration of the commercial route of community aged care. They have launched a new product “smart Magicare” in communities. The S terminal is a powerful supply chain platform, the B terminal refers to community day-care center, and the C terminal refers to aged people in the community. “Constructing a supply chain platform to connect the day-care center with the aged people in the community, and this method solves the problems happening in the last area between the communities’ aged-people care and home-base aged care,” said Wei.

At present, “smart Magicare” has seen 136 seed stores and 226 co-construction users. In the future, aged people can enjoy day care, full-time care, meal delivery, cleaning, physical therapy, door-to-door services within 1.5 kilometers and other services in the community stores of the “smart Magicare”.

Products: aged-people oriented design

Magicare has launched systematic scientific solutions for institutional aged care. The solutions include five functions: call service, active forewarning, care and nursing plan, health record and interaction with children. Li Guangpeng, CTO of Magicare, has shown the specific operation mode of the intelligent care and nursing system.

In the call service, aged people can use bracelets, breast plates and bedside alarms to realize “one-button alarm”. “According to the different needs of the aged people, we have designed the call modes for different scenes. Old people who are in good physical condition can wear the bracelet and press the alarm button when in an emergency; if aged people have difficulties in moving, and can’t press down the button of the bracelet, such as the old people with Parkinson’s disease, we have designed relatively bigger breast plate which can make calls as long as the aged people lower their heads,” said Li Guangpeng. Li Guangpeng pressed down the bracelet on the spot, and the electronic display screen of the medical nursing terminal immediately displayed the information and accurate position of the person who had made the call. “Through repetitive data operations, we have endeavored to control the positioning precision of the calling within 5 meters outdoors and 2 meters indoors. Moreover, the medical nursing personnel will wear the bracelets so that they can receive the calling information of the aged people at all times and places.”

To display the active forewarning function more vividly, Magicare has simulated the home-based life scenes of the aged people. “We will install smoke alarms and activity detectors for aged people’s activities. If aged people don’t have any activities in the room for a long time, the system will make alarms automatically,” said Li Guanpeng. Moreover, Li Guangpeng has also displayed another monitoring “Black Technology” — an intelligent mattress which can not only monitor the heart rate, breath, and body actions, but also can actively alert the medical nursing personnel if the aged person has left the bed.

Along with the painstaking work for the above-mentioned hardware facilities, the software development of Magicare followed closely. When aged people enter the aged care institutions, a suitable customized care and nursing plan will be generated automatically. When the medical nursing personnel make the daily physical examination for the aged people, the data of the results will be uploaded in real time to the Cloud to form health reports. “The medical nursing personnel don’t need to write and copy the health reports by hand. Our goal is to free the hands of them, for they should work on more efficient tasks,” Li Guangpeng said. At last, children can browse the physical condition of the aged people and interact with them through the WeChat of Magicare.

View original content to download multimedia:http://www.prnewswire.com/news-releases/he-wei-ceo-of-magicare-presenting-at-smart-city-brains-300713534.html

SINGAPORE, Sept. 12, 2018 /PRNewswire/ — Mundipharma has acquired the exclusive licensing rights for a number of P’tit Bobo children’s products to complement its existing BETADINE^TM consumer healthcare range in a deal covering the Middle East, Turkey and Africa region.

Available to children aged 6 months to 10 years, it includes Nasal Spray Isotonic for daily hygiene of nasal mucosa, Nasal Spray Hypertonic for nose decongestion in cases of runny and blocked nose, and Ear Spray to clean and safely prevent ear wax build-up. [1] 

Young children are prone to bouts of flu and colds, with some falling sick as many as 8 to 10 times a year before they reach 2 years old. [3]

With the onset of the hotter summer months in the region, young children can suffer from flu-like symptoms as a result of spending time in air-conditioned buildings or from being around large numbers of people while travelling.

A good nasal hygiene routine may help to prevent nasal dryness, colds and other infections that can cause discomfort for a child. The use of isotonic and hypertonic saline solutions to relieve nasal congestion provide valuable support for children. [2],[3],[4],[5],[6]

These all-natural over-the-counter products offer parents and caretakers an easy option for managing these conditions in children, while reducing reliance on stronger, prescription medications, including antihistamines, antibiotics and corticosteroids in addressing the symptoms of acute Upper Respiratory Tract Infections. [2],[3],[4],[5],[6]

Mundipharma CEO, Raman Singh, said: “The introduction of this range to our consumer portfolio in the Middle East, Turkey and Africa will benefit children across the region.”

“The new products are proven to be effective in helping to alleviate some of the troublesome ear nose and throat symptoms that may affect toddlers and infants, and the fact that they are all-natural should encourage parents and caregivers to adopt a more proactive and regular approach to managing them.” [3],[4],[5],[6]

About Mundipharma

Mundipharma is a network of independent associated companies, which are privately owned entities, covering pharmaceutical markets in Asia-Pacific, Latin America, the Middle East and Africa. The headquarters for these territories is in Singapore. Mundipharma consistently delivers high-quality medicines while standing by the values it represents. Its mission is to alleviate the suffering of patients and to substantially improve their quality of life. Mundipharma is dedicated to bringing to patients the benefit of novel treatment options in fields such as pain, oncology, oncology supportive care, ophthalmology, respiratory disease and consumer healthcare.

For more information, please visit:  www.mundipharma.ae

Logo – http://photos.prnasia.com/prnh/20150302/8521501264LOGO

QINGDAO, China, Sept. 13, 2018 /PRNewswire/ — Transfusion medicine has been around and under constant improvement for more than 300 years and and nowadays its delivery system of clinical blood has witnessed a landmark change. In order to address such blood-related issues as blood safety, its source and efficacy, China-based Haier Biomedical has co-created the world’s first U-Blood platform ecosystem. It fundamentally ensures the safety of clinical blood and the sharing of blood resources, offering a value-added user experience for all parties involved.

Countries around the world have been striving continually to improve their clinical blood services. And the US, being the leader in healthcare industry, has launched an advanced blood management solution. By moving type O emergency blood to the operating room, it vastly reduces the time for transferring the needed life-saving substance to patients’ side. With its proven efficiency, it has recently been deployed at Johns Hopkins Hospital.

Under that circumstance, Haier Biomedical’s U-Blood solution has vastly improved the efficiency of blood banks by literally placing the blood bank to where it is needed most – right next to the patient’s bed, which pushes the efficiency to a new level well beyond the current US standards. Through innovations in RFID IoT technology, the management model has shifted from centralized to decentralized type. The new model innovatively moves smart blood refrigerators to the operating room, hospital ward and the ambulance, achieving the end-to-end monitoring and traceability of all blood information. As a result of that, the blood is instantly accessible at hand, cutting off the valuable and life-saving time needed to deliver the blood to the patient. In addition, the Blood which is not used during the course of the surgery can be restored to the blood bank via the U-Blood monitoring equipment, which ensures true sharing of blood information and increases the hospital’s surgery capacity.

In order to further improve the blood use experience, efforts are being made to provide the precise amount of blood needed for each transfusion by developing a customized and personalized program. Furthermore, with the application of big data and artificial intelligence (AI), the patient’s consumption of blood will be comprehensively evaluated. And there is a tailored blood use program developed for monitoring the patient’s condition and diagnostic data across the entire U-Blood platform ecosystem. For example, what may have been previously required for four units of blood can be reduced to a precise need of two, as a result of a profile generated via AI, avoiding the overuse and waste of blood and accelerating the patient’s recovery.

According to authoritative analysis made by experts in the industry, U-Blood has created a new blood use model and experience which is worthy of applying around the world. To be more specific, in some recent use cases, has, at the Affiliated Hospital of Qingdao University and at the Chinese PLA General Hospital (301 Hospital) in Beijing, the U-Blood has proved its ability to offer values to hospitals, stakeholders and especially the customers. In a word, on the one hand it increases the efficiency of clinical blood use, at which blood can be acquired within one minute during the surgical process to ensure timely delivery to the patient; on the other hand it delivers precisely the right amount of blood through a personalized program, avoiding any possible harm caused by excessive infusion to the patient.

Haier Biomedical has completed its transformation from the world’s prominent full cold chain brand to an IoT-ready biotechnology platform ecosystem. And it has taken the lead in creating the U-Blood platform to eliminate the “information silo” by connecting hospitals, blood centers and governments, which enables the interoperability, traceability, and information sharing of all the blood resources. Being innovative with the move to transfer blood bank to the patient’s bedside and the ability to deliver the precise amount of blood needed, the solution ultimately enables an evolution in user experience with the implementation of the ecosystem. Furthermore, in the future, this ecosystem can be extended to a 5U biotechnology platform – a Haier Biomedical’s platform bringing together the blood, biobank, vaccine, reagent and stem cell solutions, which can efficiently accelerate the development of the global healthcare sector.

Notably, the Rendanheyi management model has played a leading role in the creation of Haier Biomedical’s platform ecosystem. Recognized as the first-of-its-kind and a revolutionary management model since the third industrial revolution, Rendanheyi has guided Haier Biomedical to transform from an equipment exporter to a business incubator. By integrating the ecosystem, the revenue derived from the ecosystem and the brand associated, the concept has also proven itself as a good fit for the business model which is ready for the world of IoT. Last but not least, recognized by international authorities and research institutions, it is now an exemplar of a management model with universal applicability and social benefits, which it has been.

View original content to download multimedia:http://www.prnewswire.com/news-releases/haier-biomedical-saves-lives-by-moving-the-blood-bank-to-the-patients-bedside-300709467.html

PARIS, Sept. 14, 2018 /PRNewswire/ —

Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone

Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report called ‘Rosacea: Beyond the visible’, assists healthcare professionals (HCPs) to identify the common characteristics of High Burden* (HB) rosacea patients. Results of the analysis have the aim of increasing tailored treatment regimens to improve patient care. Results presented during a symposium at the 27^th European Academy of Dermatology and Venerology (EADV) Congress in Paris, France, yesterday, reveal that a broader definition of HB patients is needed to help reduce burden in daily practice.

The data analysis classified HB patients based on how severely their condition impacts their quality of life (QoL), the extent to which it influences their behavior and their level of desire for a cure.^[1]

“People with rosacea are often judged on their appearance, which impacts them greatly in daily life. If their rosacea is severe, the symptoms are likely to be more significant also, from itching and burning to a permanently red central facial area. However, even people with less severe rosacea report a significant impact on quality of life, which suggests that assessing patients on clinical severity alone is not enough,” said Prof. Dr. Uwe Gieler, Dept. of Dermatology and Clinic of Psychosomatic Medicine and Psychotherapy, Justus-Liebig-University of Giessen, Germany and one of the authors of the Rosacea: Beyond the visible report. “By improving identification of this demographic, dermatologists and other healthcare professionals will be better equipped to tailor treatment to the individual’s needs and ultimately improve care for people living with this chronic skin disease.”

The data revealed HB rosacea patients were significantly younger, employed and more likely to be male, compared to their less HB peers. Another characteristic defined included an increase in skin sensations (such as itching 48% vs 37% and pain 23% vs 13%) in comparison with their less HB peers over the last 12 months.

HB risk is affected by severity of symptoms; however, this state can be associated with any severity of rosacea. When looking over 12 months, HB patients were shown to have a significant increase in risk of experiencing an impact on daily activities, such as their skin care regime, as well as experiencing discomfort due to their disease when compared to non-HB patients. Other risk-factors included; a family history of rosacea and an increase of rosacea-related Emergency Rooms visits.

Experts concluded that healthcare professionals treating rosacea patients should include questions relating to burden in everyday practice, to ensure treatment is aligned with patients’ disease experience, not just disease severity.

The presentation is titled “Defining High Burden patients” (Gieler, U. et al., 27th European Academy of Dermatology and Venerology (EADV) Congress, 13 September 2018).

*Patients were categorized as high burden (HB) when at least three of four domains were positive (threshold defined by the cohort median).

Domain Proxy question Positive threshold
QoL Overall impact on QoL (0-10) Score >5
Level of behavioral adaptation
Lifestyle (0-10) Score >6
Willingness to pay to obtain a
Economic complete cure >20% of monthly income
Willingness to trade years of
Psychosocial/emotional life for a complete cure >6 months

For related multimedia resources, please visit http://www.epresspack.net/galderma-rosacea

About Rosacea   

Rosacea is a common inflammatory skin disease that presents variable clinical characteristics, of which the most common are flushing, permanent erythema, and inflammatory lesions. It mainly affects the central areas of the face, such as the cheeks and nose. The disease can affect both adult men and women, usually after the age of 30. Additionally, symptoms such as stinging, burning and increased sensitivity of the skin are common. The eyes are often affected, and might present as red, dry or itchy.

Although the cause of the disease is still under debate, various trigger factors are known, including spicy foods, alcohol, emotional stress, sun/UV-exposure, hot baths and beverages. Demodex, generally harmless mites, can also be found in the skin in an elevated quantity in people with rosacea.

Rosacea may worsen over time if left untreated. People that suspect they suffer from rosacea should visit their dermatologist or healthcare provider for diagnosis and discuss what treatment is right for them. Because rosacea is a highly visible disease, it is known to cause embarrassment and anxiety in some patients, which in turn may cause frustration and have a negative impact on their social life.

About the BURDEN survey   

The BURDEN survey was developed by Kantar Health as a self-administered online survey and supported by Galderma. The survey involved 710 patients diagnosed with rosacea and 554 dermatologists and general practitioners (GPs) in 6 different countries (France, Germany, Italy, UK, Canada and the US). The survey asked respondents about their experience of living with, or treating patients that are living with, rosacea.

Participants were recruited using the Kantar online panel. To maximize the sample size no quota was set up. Therefore, the sample is not representative of the rosacea population of each country; consequently, the results of this study could be affected by selection bias and cannot be inferred to the whole rosacea population.

About Galderma  

Galderma, Nestlé Skin Health’s medical solutions business, was created in 1981 and is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit http://www.galderma.com

References:   

1. Galderma data on file.

LONDON, Ontario, Sept. 14, 2018 /PRNewswire/ — Trudell Medical International (TMI) is excited to announce its new High-Altitude Sleep Mask is now approved for sale in Austria, Belgium, France, Germany, Italy, the Netherlands, Spain, Switzerland, and the United Kingdom.  

High Altitude Sleep Mask shown on model

Venturing to high-altitude locations is increasingly common, and more and more people are being exposed to the effects of these hypoxic environments. TMI’s High-Altitude Sleep Mask is a new Class I medical device that provides a combination of mild exhalation resistance and CO₂ rebreathing.  The result is a drug-free method of mitigating the effects of disrupted sleep at high-altitude by reducing high-altitude periodic breathing.¹  An added benefit of the TMI High-Altitude Sleep Mask is that rebreathing improves the heat and humidity of inhaled air in the typical cold, dry environment at altitude.

Equally exciting is that a recent pilot study shows that TMI’s High-Altitude Sleep Mask also reduces the severity of high-altitude headaches, the most common symptom of Acute Mountain Sickness (aka altitude sickness). ¹

For more information please visit www.altimatemask.com

¹ Based on unpublished results from a pilot study completed in March 2018

Jason Collins, Director Commercial Development, Trudell Medical International, JCollins@trudellmed.com, +1-519-455-7060 ext 2202

Photo – https://mma.prnewswire.com/media/744355/SleepMask_in_use.jpg

BEIJING, Sept. 13, 2018 /PRNewswire/ — Infinitus (China) Company Ltd. was honoured with a China Charity Award from the Ministry of Civil Affairs for its long-term commitment to corporate social responsibility (CSR) and innovation at the 10th China Charity Awards ceremony held in the Great Hall of the People on September 13. The ceremony was chaired by Mr. Huang Shuxian, Minister of the Civil Affairs and attended by government leaders who presented awards to the winners. Mr. Huang Jianlong, Vice President of Si Li Ji Ren Foundation and Senior Vice President of Infinitus (China) Co., Ltd., received the award on behalf of Infinitus.

Mr. Huang Jianlong, Vice President of Si Li Ji Ren Foundation and Senior Vice President of Infinitus (China) Co., Ltd, received the China Charity Award on behalf of Infinitus

The China Charity Awards is the highest level of recognition from a government authority in term of philanthropy in China. It was established in 2005 and has been held for ten consecutive years. Now at its tenth session, after one-year strict selection process by the jury, 28 charitable role models, 37 firms, 16 individuals and 49 programs were granted the coveted honour. It’s the second time that Infinitus has been awarded the honour since 2006.

Si Li Ji Ren: working for the social good

Since its establishment, Infinitus has been committed to promoting the premium Chinese health regimen and nurturing healthier lives with balance, affluence and harmony. Backed by the company’s organic growth, Infinitus has put in place a unique CSR system consisting of a core value, a CSR report, a public welfare foundation, a volunteer team and a signature public welfare program.

Infinitus Happy Football Programme

Si Li Ji Ren describe the core values that have acted as an anchor for Infinitus since inception and serve as the firm’s leading principles and approach to CSR.

Infinitus has issued 11 reports detailing the progress of its CSR activities since 2008, giving employees an opportunity to fully understand why their work matters and helping partners increase their awareness of what Infinitus does. Infinitus’ CSR reports have been honoured with the GoldenBee CSR Report Evergreen Award for four years running.

In 2012, with the approval of the Ministry of Civil Affairs, Infinitus donated RMB 20 million (approx. USD 2.9 million) to set up the privately-run Si Li Ji Ren Foundation. The foundation has since donated over RMB 76 million (approx. USD 11 million).

In 2016, Infinitus kicked off the volunteer project and set up the Infinitus Volunteers Association with a membership consisting mainly of employees and distributors. It assembled 33 volunteer teams across China. To date, the association has had more than 6,000 volunteers, organized 230 volunteer events, accumulating more than 27,000 hours of volunteer work.

Together with the Si Li Ji Ren Foundation, Infinitus has helped employees and distributors maximize their charitable contributions and explored innovative philanthropy models by holding a variety of public welfare events, including Infinitus Walking Day, Si Li Ji Ren Education Dream Support Programme and Infinitus Happy Football Programme.

The company has also continued to invest in public health, poverty alleviation, teaching assistance and disaster relief. In addition to investing in the establishment of 21 primary schools under the Infinitus name, it has held a number of public welfare events, including the Health Maintenance Promotion for Families, the Infinitus Anti-Drug Community Book Conrners, the China Lifeline Express, the Tonifying and Modulating for Youth Health Project, and the Infinitus Police Health Improvement Fund. Furthermore, Infinitus responded rapidly after natural disasters, including the Wenchuan, Yushu and Ya’an earthquakes as well as the drought in Southwest China. To date, the company has donated RMB 220 million in cash and kind.

Infinitus has partnered with stakeholders to establish alliances with the goal of expanding its CSR efforts. In November 2016, the company joined hands with the Si Li Ji Ren Foundation and the Infinitus Volunteer Association in concert with 51 suppliers to set up the Healthcare Alliance with the aim of promoting a healthy lifestyle and outlook on life among its own members and encouraging them to take part in public welfare activities. It is the first corporate volunteer alliance following the Chinese government’s issuing of the “Healthy China 2030” strategy.

In 2017, Infinitus proactively responded to the Sustainable Development Goals (SDGs) launched by the United Nations, and established the action framework in four aspects of Health, People, Earth and Community, with a focus on four SDGs – Good Health and Well-Being, Partnerships for the Goals, Responsible Consumption and Production, Partnerships for the Goals, and Quality Education. It issued the Infinitus Sustainable Development Goals White Paper in June 2018, which is the first SDGs white paper in the herbal health industry in China.

Looking forward, Infinitus, based on the UN’s SDGs and CSR practices concerning Health, People, Earth and Community, plans to provide high-quality products and services while creating more value, in an effort to make its contribution to meeting the sustainable development goals. 

Photo – https://photos.prnasia.com/prnh/20180913/2232593-1-a
PHoto – https://photos.prnasia.com/prnh/20180913/2232593-1-b

Source: Infinitus (China) Company Ltd.